Clinical Trial Update: Spinal Cord Injury Neuroprotection With Glyburide [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating glyburide for neuroprotection in acute spinal cord injury and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Glyburide (glyburide)

Snippet

Sponsor: Francis Farhadi | Conditions: Acute Spinal Cord Injury | Phase 1 | Status: RECRUITING